Susan Tousi has over 25 years of R&D and business leadership experience across the life sciences and technology industries. As of January 2024, she served as the Chief Executive Officer of DELFI Diagnostics, Inc. She served as Illumina's Chief Commercial Officer for almost three years. Before that, she led the product development organization at Illumina as Chief Product Officer responsible for global engineering, consumables, sequencing applications, IVD, software, and informatics development efforts. Illumina products launched under Ms. Tousi's oversight include HiSeq X, NovaSeq 6000, NextSeq 550Dx/10...read more